A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.

Simon Gampenrieder; A Risch; G Rinnerthaler; H Hackl; M. Steiner; Walter Pulverer; Andreas Weinhäusel; Suzana Ilic; Clemens Hufnagl; Cornelia Hauser-Kronberger; A Egle; R. Greil

A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.

Simon Gampenrieder (Vortragende:r)
, A Risch
, G Rinnerthaler
, H Hackl
, M. Steiner
, Walter Pulverer
, Andreas Weinhäusel
, Suzana Ilic
, Clemens Hufnagl
, Cornelia Hauser-Kronberger
, A Egle
, R. Greil

Molecular Diagnostics

Publikation: Posterpräsentation ohne Beitrag in Tagungsband › Posterpräsentation ohne Eintrag in Tagungsband › Begutachtung

Originalsprache	Englisch
Publikationsstatus	Veröffentlicht - 2018
Veranstaltung	San Antonio Breast Cancer Symposium 2018 - Dauer: 4 Dez. 2018 → 8 Dez. 2018

Konferenz

Konferenz	San Antonio Breast Cancer Symposium 2018
Zeitraum	4/12/18 → 8/12/18

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Research Field

Molecular Diagnostics

Diese Publikation zitieren

Gampenrieder, S., Risch, A., Rinnerthaler, G., Hackl, H., Steiner, M., Pulverer, W., Weinhäusel, A., Ilic, S., Hufnagl, C., Hauser-Kronberger, C., Egle, A., & Greil, R. (2018). A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.. Beitrag in San Antonio Breast Cancer Symposium 2018.

@conference{e6e5b0662bd94b1bb934c10b531e0913,

title = "A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.",

author = "Simon Gampenrieder and A Risch and G Rinnerthaler and H Hackl and M. Steiner and Walter Pulverer and Andreas Weinh{\"a}usel and Suzana Ilic and Clemens Hufnagl and Cornelia Hauser-Kronberger and A Egle and R. Greil",

year = "2018",

language = "English",

note = "San Antonio Breast Cancer Symposium 2018 ; Conference date: 04-12-2018 Through 08-12-2018",

}

Gampenrieder, S, Risch, A, Rinnerthaler, G, Hackl, H, Steiner, M, Pulverer, W , Weinhäusel, A, Ilic, S, Hufnagl, C, Hauser-Kronberger, C, Egle, A & Greil, R 2018, 'A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.', Beitrag in San Antonio Breast Cancer Symposium 2018, 4/12/18 - 8/12/18.

A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial. / Gampenrieder, Simon (Vortragende:r); Risch, A; Rinnerthaler, G et al.
2018. Beitrag in San Antonio Breast Cancer Symposium 2018.

Publikation: Posterpräsentation ohne Beitrag in Tagungsband › Posterpräsentation ohne Eintrag in Tagungsband › Begutachtung

TY - CONF

T1 - A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trial.

AU - Risch, A

AU - Rinnerthaler, G

AU - Hackl, H

AU - Steiner, M.

AU - Pulverer, Walter

AU - Weinhäusel, Andreas

AU - Ilic, Suzana

AU - Hufnagl, Clemens

AU - Hauser-Kronberger, Cornelia

AU - Egle, A

AU - Greil, R.

A2 - Gampenrieder, Simon

PY - 2018

Y1 - 2018

M3 - Poster presentation without proceedings

T2 - San Antonio Breast Cancer Symposium 2018

Y2 - 4 December 2018 through 8 December 2018

ER -